Human Resouces and Services
Health Care Costs: Do We Need a Cure?
Published In: Volume 3, Issue 2: Modern Healthcare Policy — November 5, 2006
Dr. Karen Feinstein
President and CEO, The Jewish Healthcare Foundation
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Dr. Jonathan Gruber
Professor of Economics, MIT
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Redesigning the US' Healthcare Model
We must take steps towards solving the nation’s health care crisis, without employing elements of failed private managed care.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
The Medicare Prescription Drug Benefit
Serious flaws; should be amended, not repealed.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
The MMA should be repealed and replaced
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Healthcare Delivery Systems in Rural India
Meeting the changing needs of rural populations
How will India’s delivery of healthcare impact its future success as a global competitor? The author assesses the ways in which India’s current healthcare system both fails and succeeds in serving India’s rural population and looks at the impact this may have on the country’s future.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Outsourcing Care
Replacing Medicaid with Cross-Border Care in Texas
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Mental Health Parity
Legislation and Implications for Insurers and Providers
Ten years after the Mental Health Parity Act passed, which mandated equitable insurance coverage for mental health problems, insurers and providers still debate the issue.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Price Controls on U.S. Pharmaceuticals
Is this Good Public Policy?
The structure of the US pharmeceutical industry has given drug manufactures a large degree of control on the price of new medications. This article explores the implications of price controls on the pharmaceutical industry, weighs the benefits and costs of regulation, and compares the United States with international examples of price controls.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
A Conversation with Leo W. Gerard
Published In: Volume 3, Issue 1: Globalization and its Implications — March 24, 2006
Systems Synthesis: Boards, Authorities, and Commissions Research Project
On Thursday, August 4, 2005, the Boards, Authorities, and Commissions Research Project Team presented its research and held a press conference on the policy issue of fair representation for elected officials, civic and community leaders and affiliates of the Heinz School. Fair representation addresses the demographic composition of those appointed to non-elected public entities in the City of Pittsburgh and in Allegheny County; the research is focused specifically on the representation of women and African-Americans who historically have not been represented in the pool of candidates for appointments. This document presents the team’s proposed plan for action by the local governments of the Greater Pittsburgh Region.
Published In: Volume 2, Issue 2: — October 15, 2005
Child Care Subsidies in the Context of Welfare Reform
Making Low-Income Women Better Off?
Published In: Volume 2, Issue 2: — October 7, 2005
Offshore Outsourcing: Sizable Rhetoric and Little Progress
Published In: Volume 1, Issue 2: — October 15, 2004